[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353700-105":59,"doc-detail-353700-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","research-progress-on-the-correlation-between-opn-and-immune-escape-of-gastric-cancer","Research progress on the correlation between OPN and immune escape of gastric cancer","","Immunotherapy using programmed death receptor 1 (PD-1) inhibitors has improved outcomes for gastric cancer, yet only a subset of patients achieves durable benefit. Immunotherapy failure is largely linked to tumor microenvironment-driven immune tolerance. Osteopontin (OPN) is reported to promote tumor progression through effects on tumor cell survival, angiogenesis, and immune microenvironment regulation. This review summarizes OPN’s role in gastric adenocarcinoma development and highlights current progress on OPN-mediated immune escape, including potential mechanisms of synergy between OPN and PD-L1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/research-progress-on-the-correlation-between-opn-and-immune-escape-of-gastric-cancer/353700/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/research-progress-on-the-correlation-between-opn-and-immune-escape-of-gastric-cancer/353700.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do PD-1 checkpoint inhibitors fail in some gastric cancer patients?","Question",{"text":112,"@type":113},"Failure is mainly related to induction of immune tolerance within the gastric cancer tumor microenvironment, which allows immune escape.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does osteopontin (OPN) play in gastric cancer?",{"text":117,"@type":113},"OPN promotes tumor progression by multiple mechanisms, including influencing tumor cell survival, tumor angiogenesis, and regulating the tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"How is OPN connected to immune escape and PD-L1 in gastric adenocarcinoma?",{"text":121,"@type":113},"The review focuses on OPN’s involvement in immune escape of gastric adenocarcinoma and the synergistic effect between OPN and PD-L1, including potential mechanisms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353700,1790406902,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Clinical and Experimental Medicine (2026) 26:157  \n[https://doi.org/10.1007/s10238-026-02075-w](https://doi.org/10.1007/s10238-026-02075-w)  \nREVIEW  \nResearch progress on the correlation between OPN and immune escape of gastric cancer  \nFanjie Qu1 · Shuang Wu1 · Weiwei Yu1  \nReceived: 16 September 2025 / Accepted: 21 January 2026 © The Author(s) 2026  \nAbstract  \nIn recent years, immunotherapy represented by programmed death receptor 1 (PD-1) inhibitors has significantly improved the prognosis of patients with gastric cancer, making the immunotherapy of gastric cancer a focus of clinical attention. Although immune checkpoint inhibitors (ICIs) have achieved breakthroughs in immunotherapy, only a portion of patients have achieved promising long-term results in response to checkpoint inhibitors, indicating the existence of other unknown tumor-induced immunosuppressive pathways. The failure of immunotherapy is mainly related to the induction of immune tolerance in the tumor microenvironment of gastric cancer. Therefore, solving the problem of tumor immune tolerance is the key to the success of immunotherapy for gastric cancer. Studies have found that OPN promotes tumor progression through multiple mechanisms such as influencing tumor cell survival, tumor angiogenesis, and regulating the tumor microenvironment. For this purpose, we review the role of OPN in the occurrence and development of gastric adenocarcinoma, and focus on reviewing the current research progress of OPN in inducing immune escape of gastric adenocarcinoma and the synergistic effect between OPN and PD-L1 and its potential mechanisms, laying the foundation for the development of immunotherapy combination methods based on OPN in future.  \nKeywords Osteopontin · Gastric cancer · Immunotherapy · Immune tolerance  \nIntroduction  \nMost advanced gastric cancers have a poor prognosis. It is reported that the 5-year survival rate of patients with advanced gastric cancer is 19% to 31%[1, 2] . Scientists have discovered that cancer cells can evade the immune system through various mechanisms, including inhibiting antitumor effector T cells through the interaction of immune checkpoint ligands and receptors, and blocking these pathways can revitalize anti-tumor immunity. In recent years, immune checkpoint inhibitor (ICIs) immunotherapy has made breakthroughs in many human cancers, including gastric cancer. Several phase III studies such as CheckMate-649  \nFanjie Qu and Shuang Wu contributed equally to this work.  \n􀀍 Fanjie Qu [wyb960419@163.com](wyb960419@163.com)  \n1 Department of Oncology, Dalian Third People’s Hospital Affiliated to Dalian University of Technology, No. 40 Qianshan Road, Ganjingzi District, Dalian 116033, Liaoning Province, China  \nand ATTRACTION-4 have explored the first-line treatment of advanced gastric cancer with ICIs combined with chemotherapy. Based on the results of these studies, the guidelines and clinical practice of gastric cancer have been rewritten [3–5] .  \nHowever, only a portion of gastric cancer patients have achieved promising long-term outcomes in their response to checkpoint inhibitors. Different molecular subtypes have different sensitivities to immunotherapy. For example, microsatellite height instability (MSI-H), Epstein-Barr virus (EBV) -positive tumors have different responses to immunotherapy, and HER2-positive patients have a better objective response rate to ICIs treatment, etc. Some genomic sequencing studies have shown that high levels of PD-L1 expression are associated with Epstein-Barr virus (EBV) and microsatellite instability (MSI) molecular subtypes of gastric cancer, and have a better response to immune checkpoint inhibitors at the same time [6, 7] . Regrettably, some patients with gastric cancer do not benefit significantly in their response to checkpoint inhibitors. Studies have found that for patients with PD-L1 CPS \u003C 5 points, the efficacy of ICIs combined with chemotherapy remains controversial.  \n1 3  \nThe analysis","cbCaikeehIWn111C","https://ap.wps.com/l/cbCaikeehIWn111C","pdf",1417406,"English","# Abstract\n# Introduction\n## Immune checkpoint inhibitors and limitations\n## Molecular subtypes and PD-L1 expression\n## Immune tolerance and tumor microenvironment\n## Combined immunotherapy strategies","[{\"question\":\"Why do PD-1 checkpoint inhibitors fail in some gastric cancer patients?\",\"answer\":\"Failure is mainly related to induction of immune tolerance within the gastric cancer tumor microenvironment, which allows immune escape.\"},{\"question\":\"What role does osteopontin (OPN) play in gastric cancer?\",\"answer\":\"OPN promotes tumor progression by multiple mechanisms, including influencing tumor cell survival, tumor angiogenesis, and regulating the tumor microenvironment.\"},{\"question\":\"How is OPN connected to immune escape and PD-L1 in gastric adenocarcinoma?\",\"answer\":\"The review focuses on OPN’s involvement in immune escape of gastric adenocarcinoma and the synergistic effect between OPN and PD-L1, including potential mechanisms.\"}]","Research progress on the correlation between OPN and immune escape of gastric cancer | PDF",1790106793,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db72b4b8600b37a70e7394c075af9d0f.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d5974614bf8eb6d8db06b35094605d3.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d028164a1e9017ac13afb3d13910192f.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35080b6076c11abab12f9ad6af3ff742.webp",980,1301]